Exane Derivatives’s iShares iBoxx $ Investment Grade Corporate Bond ETF LQD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-1,200
Closed -$72K 854
2020
Q3
$72K Hold
1,200
0.02% 345
2020
Q2
$143K Buy
1,200
+300
+33% +$39K 0.04% 240
2020
Q1
$645K Sell
900
-920
-51% -$117K 0.18% 107
2019
Q4
$113K Buy
1,820
+300
+20% +$38.2K 0.02% 307
2019
Q3
$71.3K Hold
1,520
0.01% 346
2019
Q2
$113K Buy
1,520
+600
+65% +$72.1K 0.02% 320
2019
Q1
$57.2K Hold
920
0.01% 331
2018
Q4
$503K Hold
920
0.09% 176
2018
Q3
$250K Hold
920
0.05% 228
2018
Q2
$604K Buy
+920
New +$106K 0.1% 162

Other funds holding LQD

Exane Derivatives's LQD Position: Q2 2021 in Review

Exane Derivatives sold out of iShares iBoxx $ Investment Grade Corporate Bond ETF (LQD) in Q2 2021, closing a stake of 370 shares — an estimated $48.1K sold.

Exane Derivatives first reported a position in LQD in Q4 2014 and held it in 22 quarters. The position peaked at $4.59M in Q1 2020. 1,055 funds tracked by Wall St. Rank hold LQD as of Q2 2021.

  • Exane Derivatives reported no remaining iShares iBoxx $ Investment Grade Corporate Bond ETF position as of Q2 2021 after selling out during the quarter.
  • Exane Derivatives sold 370 iShares iBoxx $ Investment Grade Corporate Bond ETF shares in Q2 2021, an estimated $48.1K.
  • Exane Derivatives first reported a position in iShares iBoxx $ Investment Grade Corporate Bond ETF in Q4 2014 and held it in 22 quarters.
  • Exane Derivatives's iShares iBoxx $ Investment Grade Corporate Bond ETF position peaked at $4.59M in Q1 2020.
  • 1,055 funds tracked by Wall St. Rank held iShares iBoxx $ Investment Grade Corporate Bond ETF as of Q2 2021.

Based on Exane Derivatives's 13F filing for Q2 2021, filed 28 Jul 2021.